Michael Brooks, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 420 Bracey Ln, South Hill, VA 23970 Phone: 434-447-7765 |
Miguel A Vega Gilormini, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1755 N Mecklenburg Ave, South Hill, VA 23970 Phone: 434-584-5567 Fax: 434-584-5570 |
Newton Miller, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 413 Bracey Ln, South Hill, VA 23970 Phone: 434-447-7765 |
Dr. Kwadwo Boadi Baryeh, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1755 N Mecklenburg Ave, South Hill, VA 23970 Phone: 434-584-5567 Fax: 434-584-5570 |
Mr. Chakkris Siri, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 420 Bracey Ln, South Hill, VA 23970 Phone: 434-447-7765 Fax: 434-447-4011 |
Dr. Darrell James Brown Jr., MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1755 N Mecklenburg Ave, South Hill, VA 23970 Phone: 434-447-0876 |
News Archive
As many as one in seven people will experience tinnitus, or ringing in their ears, at some time of their life, but not enough is being done to support patients who experience this distressing condition, according to an extensive research review in the November issue of the Journal of Clinical Nursing.
According to a recent study in the Archives of Internal Medicine, 75 percent of Americans do not get enough Vitamin D.
The U.S. Food and Drug Administration today approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation (IBS-C) in adults.
Jopari Solutions, the principal supplier of medical EDI services and connectivity networks to Providers and Payers in Property & Casualty markets, and Noble House, a software leader for billing and claims management for DME/HME, today announced a strategic partnership to advance medical billing and processing.
IQ Therapeutics B.V., Groningen, the Netherlands, announced this week that in collaboration with the University of Texas Medical Branch it has obtained outstanding results for the treatment of inhalation anthrax. In a rabbit model up to 100% survival could be achieved with extended time to treatment (48h post infection) with a combination of two specific monoclonal antibodies developed by IQ Therapeutics. This has significant potential for saving lives of infected people who have no immediate access to treatment.
› Verified 8 days ago